The “What I Wish I Knew” series of articles is a service of CPNP’s Resident and New Practitioner Committee. Articles are intended to provide advice from experts for students, residents, and new practitioners. Articles are not intended to provide in-depth disease state or pharmacotherapy information nor replace any peer-reviewed educational materials. We hope you benefit from this “field guide” discussing approaches to unique problems and situations.

Matthew A. Fuller, Pharm.D, BCPP, FASHP
Clinical Pharmacy Specialist, Psychiatry
Louis Stokes Cleveland VA Medical Center, Cleveland OH
Clinical Professor of Psychiatry and Psychology
Case Western Reserve University School of Medicine, Cleveland OH
Adjunct Associate Professor of Clinical Pharmacy
University of Toledo School of Pharmacy, Toledo OH

Dr. Fuller has over 33 years of experience as a pharmacist. His primary practice site is acute inpatient psychiatry where he also serves as the Residency Program Director for an ASHP accredited PGY2 Psychiatric Pharmacy Residency Program. He is a Past President of the College of Psychiatric and Neurologic Pharmacists and the current President of the College of Psychiatric and Neurologic Pharmacists Foundation. He remains active in scholarly pursuits with research and publication, has presented at local, state, national and international venues and serves as a reviewer for multiple psychiatric and pharmacy journals. He has notably served as a member of the Editorial Board Panel on Psychiatry for The Annals of Pharmacotherapy as well as Lexi-Comp’s editorial advisory panel. His personal interests in research and clinical practice include novel strategies for the management of schizophrenia and bipolar disorder.

What Is The Most Important Factor In Developing A Case Report?

Make sure you have the facts and details correct and that you establish the sequence for the events that you want to report. The facts may include the nature and time course of the event, laboratory data, medications and disease states.

How Do You Know When Your Case Is "Publish Worthy"?

Why are you thinking about publishing a case report? Generally, because what you are seeing in your patient(s) clinically does not support what you know/is known about a drug or drugs (remember to consider drug-drug interactions as a possibility). You also want to add to the medical literature so that other health care professionals are able to learn from your information and potentially spur ideas for conducting research.

Is what you are describing unique? Search the medical literature and the drug’s package insert to determine if what you discovered is unique. If there are previous case reports published, what makes your case different? You will need to acknowledge previous information and describe the differences in your case and what you are reporting. Is the sequence logical? Did you do a Naranjo probability test? Are there alternative explanations for what you are describing? If there are alternative explanations, this will diminish the publishability of your case. However, you should use the discussion section of the report to rebut possible alternative explanations to support your assertion of causality. In other words, convince the reviewer and reader that what you are reporting is likely.

What Are Some Strategies For Assembling A Case Report And The Submission Process?

Review pharmacy and medical journals that publish material related to your case. For example, if you are reporting a new adverse reaction related to a mental health medication you may consider: The Mental Health Clinician or American Journal of Psychiatry. Determine if the journal accepts case reports. If so, review their “Author Guidelines” on their website. Follow the guidelines closely, paying attention to word count, format, and any figure/reference guidelines. The following are generally necessary items for every journal: background, case report, discussion, conclusions, references. If working with others, divide the work but be sure to discuss authorship. Sometimes it is helpful to have a medical expert review your report for their input and edits. It will offer a review from another set of eyes and may fuel future collaboration.